MENU
+Compare
IVBXF
Stock ticker: OTC
AS OF
Jul 3 closing price
Price
$10.50
Change
+$0.26 (+2.54%)
Capitalization
17.99B

IVBXF Innovent Biologics Inc. Forecast, Technical & Fundamental Analysis

Innovent Biologics, or Innovent, is one of the leading biotechnology companies in China... Show more

IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IVBXF with price predictions
Jul 03, 2025

IVBXF in downward trend: price may drop because broke its higher Bollinger Band on June 09, 2025

IVBXF broke above its upper Bollinger Band on June 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 31 similar instances where the stock broke above the upper band. In of the 31 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IVBXF moved out of overbought territory on June 26, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for IVBXF turned negative on June 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on IVBXF as a result. In of 66 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 201 cases where IVBXF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IVBXF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.398) is normal, around the industry mean (16.678). P/E Ratio (0.000) is within average values for comparable stocks, (58.763). IVBXF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (13.004) is also within normal values, averaging (269.614).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
168 Dongping Street
Phone
+86 51269566088
Employees
5294
Web
https://www.innoventbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
NMR.X7.4072100.149312
+2.06%
Numeraire cryptocurrency
ALGO.X0.1770680.002428
+1.39%
Algorand cryptocurrency
PERL.X0.0003570.000005
+1.34%
PERL.eco cryptocurrency
ELF.X0.1926620.000794
+0.41%
aelf cryptocurrency
IDEX.X0.016898-0.000998
-5.58%
IDEX cryptocurrency

IVBXF and Stocks

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
+2.49%
WXXWY - IVBXF
22%
Poorly correlated
+0.08%
ONC - IVBXF
22%
Poorly correlated
+0.48%
MDWD - IVBXF
20%
Poorly correlated
+1.15%
IVEVF - IVBXF
15%
Poorly correlated
N/A
INTI - IVBXF
11%
Poorly correlated
N/A
More